65 ABBV-744 shows potent anti-proliferative effects against. Les inhibiteurs spécifiques du. Available to order from Sigma-Aldrich. GSK778 (iBET-BD1) is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. GSK778 (iBET-BD1) is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. Copy Link. Available to order from Sigma-Aldrich. 33DFTG (TD139) $21. WGK 3. Available to order from Sigma-Aldrich. GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. In almost half of hepatocellular carcinoma (HCC) cases, the Akt pathway is activated. 1 μg/mL, which we determined was the equivalent of 1000 units/mL (U/mL) via in-house Griess assay. Of these, only ABBV-744 and two molecules described within the article, GSK778 (iBET-BD1) and GSK046 (iBET-BD2) showed appreciable selectivity. Applications Products Services Documents Support. GSK778 (iBET-BD1) potently inhibits numerous cancer cells proliferation, inducing cell cycle arrest and apoptosis. 1iBET-BD1 (GSK778) Following the initial report of the biological activity of iBET-BD1 and iBET-BD2, 19 Wellaway et al. Email. GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. Get latest info on GSK778, suppliers, manufacturers, wholesalers, traders with GSK778 prices for buying. GSK778 (iBET-BD1) [GSK reference 1, 5] is an analogue of I-BET151 [68] with good potency against BET BD1s (IC 50 s ≈ 40–75 nM) and similar selectivity to LT052 between the BDs of BRD4 (110-fold -to 140-fold depending on assay format), but this selectivity is slightly lower for BRD2 and BRD3 (30–65-fold). 11 - Combustible Solids. Available to order from Sigma-Aldrich. Copy Link. COO/ COA. 5. P (moc. 1 μg/mL, which we determined was the equivalent of 1000 units/mL (U/mL) via in-house. Applications Products Services Documents Support. Storage Class Code. 2451862-42-1. The bromodomain (BD) is a ~110 amino acid motif that binds to acetyl-lysine modifications on histone and non-histone proteins (Dhalluin et al. SML3234. ≥98% (HPLC)Comparison of the binding modes of CDD-956 with BD1, CDD-1302 with BRDT-BD2 , and iBET-BD1 (GSK778) with BRD4-BD1 (Fig. HY-136570 25mg GSK778 CAS: 2451862-42-1 GSK778 (iBET-BD1) is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2. K. GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. *. Available to order from Sigma-Aldrich. GSK778 Hydrochloride. Probe criteria. GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. Pan-BD1 inhibitors (which have higher inhibitory activity for BD1 than BD2 of BET proteins) are comparable to pan-BD inhibitors, such as MS436, 59 Olinone, 60 MS402, 61 3U, 62 GSK778, 19 ZL0516, 63 UMN627, 64 and GSK789. Drug Formulation: This drug may be formulated in DMSO. Safety Information. SML3234. All Photos (1) SML3234. GSK778 Hydrochloride. Email. 11 - Combustible Solids. Safety Information. Email. 65 In turn, pan-BD2 inhibitors (which have higher inhibitory activity for BD2 than BD1 of BET family members) are. Available to order from Sigma-Aldrich. All Photos (1) Documents. However, many compounds reported in the literature and routinely. BET BD1 related products. $21. Recently, BET proteins inhibitors that selectively target BD1 (GSK778, MS-436, Olinone, and BI-2536) and BET proteins inhibitors that selectively target BD2 (GSK046, RVX-208, RVX-297, ABBV-744) have been developed [42-47]. GSK778. S9684: GSK046Visit ChemicalBook To find more GSK778(2451862-42-1) information like chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight, physical properties,toxicity information,customs codes. The structures of the two predominant metabolites (M4 and M5) of RVX-208, observed both in in vitro human and animal liver microsomal incubations, as well as in plasma from animal in vivo studies, were determined. DC42300: GSK620:manuscript, GSK778 and GSK046 are termed iBETBD1 and - iBET-BD2 respectively. 포함:구조식 이미지,카스 번호(CAS),분자식,녹는점,끓는 점,밀도. Additionally, while GSK778 phenocopied I-BET151 in terms of anti-proliferative effects on a range of human cancer cells, GSK046 was less effective. SML3234. CAS No. Available to order from Sigma-Aldrich. GSK778 Hydrochloride. SignificanceBET bromodomain inhibition is therapeutic in multiple diseases; however, pan-BET inhibitors have induced significant myelosuppression and gastrointestinal toxicity, perhaps due to inhib. GD EN. Copy Link. a Left panel: MK2206-resistant cell lines were established by growing T47D and ZR75 cells in increasing. GSK778 (iBET-BD1) is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively. Available to order from Sigma-Aldrich. Download scientific diagram | Inhibition of CDK6 confers drug sensitivity to AKTi. GSK778 (iBET-BD1) is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and. GSK778 (iBET-BD1) is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. Applications Products Services Documents Support. Storage Class Code. 2 (LPS-PBMC assay) <10. 2h 04m. ChemicalBook 致力于为化学行业用户提供FREEBASE的性质、化学式、分子式、比重、密度,同时也包括FREEBASE的沸点、熔点、MSDS、用途、作用、毒性、价格、生产厂家、用途、上游原料、下游产品等信息。 Recently, Gilan et al. ≥98% (HPLC)GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. Open in a. All Photos (1) SML3234. GSK778 (iBET-BD1) is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively. ≥98% (HPLC)MOscan analysis of GSK778 indicated the binding of this compound only to BET bromodomains with strong binding to BET BD1 domains while weakly binding to BET BD2 domains. 12:01PM IST Vir Savarkar (Port Blair) - IXZ. WGK. Figure 5. Email. , 1999). Le GSK778 montre également de forts effets anti-cancéreux in vivo, prolongeant la survie de souris atteintes de leucémies myéloïdes aiguë [422, 423]. Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). Sigma-Aldrich. Last but not the least, GSK778 offers a superior survival advantage to iBET-BD2 in the aggressive MLL-AF9 AML model. GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. Resolution:A concentration of 1-2 µM of I-BET151, GSK778, GSK789, or GSK046 was used for cell culture treatments as recommended by our collaborators at GlaxoSmithKline (54–56). , 2012). Molecular Weight: 511. 7 B) indicated that GSK778 maintains all of the critical interactions of I-BET151 with BRD4-BD1, including the hydrogen bonding interaction of the 3,5-dimethylisoxazole moiety with the conserved Asn140, the hydrophobic interaction of the aryl ring of the α-methylbenzyl group with the. Available to order from Sigma-Aldrich. GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. A concentration of 1-2 µM of I-BET151, GSK778, GSK789, or GSK046 was used for cell culture treatments as recommended by our collaborators at GlaxoSmithKline (54–56). e. Copy Link. GSK778, also known as iBET-BD1, is a potent and selective inhibitor of bromodomain (BRD) BD1, with IC50s of 75 nM (BRD2 BD1). GSK778 (iBET-BD1) ist ein potenter und selektiver BD1-BromodomÄnen-Inhibitor der BET-Proteine mit IC50-Werten von 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1) und 143 nM (BRDT BD1) , beziehungsweise. ksg@ahjnirp. GSK778. Drugs that inhibit both bromodomains equally have shown efficacy in certain malignant and inflammatory conditions. But, how does GSK778 work on the target? Let’s discuss it in detail. Cell lysates were separated by SDS-PAGE on [email protected] μg/mL, which we determined was the equivalent of 1000 units/mL (U/mL) via in-house. MM EN. GSK778 Hydrochloride. ([email protected]) under a material transfer agreement with GSK. 1B, fig. GSK778 (iBET-BD1) is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. 999. Of these, only ABBV-744 and two molecules described within the article, GSK778 (iBET-BD1) and GSK046 (iBET-BD2) showed appreciable selectivity. GSK778 (iBET-BD1) is a strong BD1 bromodomain inhibitor of the BET proteins, with IC50 value of 75. Introduction. (C) X-ray crystal structure of I-BET151 in. Immunoblots. Available to order from Sigma-Aldrich. 13 The pyrrolidinyl group interacts with a nonconserved Asp on D1s (His on D2s) via a water-bridged hydrogen bond (Figure 1A, ,B B). IL EN. IQ EN. Products are for research use only. Available to order from Sigma-Aldrich. Drugs that inhibit both bromodomains equally have shown efficacy in certain malignant and inflammatory conditions. BD1 selective inhibitors, such as GSK778, MS-436, Olinone, and BI-2536, as well as the BD2 selective inhibitors RVX-208, RVX-297, GSK046, and ABBV-744 have been produced. GSK778 Hydrochloride. GSK778 (iBET-BD1) is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. GSK778 Hydrochloride. Copy Link. The authors report the development of GSK046 (iBET-BD2), a potent BD2-selective inhibitor with >1000-fold selectivity over BD1. Herein, GSK778 and GSK046 are referred to as iBET-BD1 and iBET-BD2, respectively. Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months). Not for human use. COO/ COA. DNA/RNA Synthesis Inhibitor/Blocker. R (moc. GSK778 phenocopies the. ≥98% (HPLC)GSK778 (iBET-BD1) is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. 451491-47-7 CTB (Cholera Toxin B subunit) is an activator of p300 histone acetyltransferase and induces apoptosis in MCF-7 cells. The second-generation BRD4 inhibitors are mainly synthesized by proteolysis targeting chimera (PROTAC) technology. Miransertib target all three Akt isoforms by blocking…. K. In addition, while GSK778 phenocopied I-BET151 in terms of antiproliferative effects on a range of human cancer cells, GSK046 was less effective. GSK778 Hydrochloride. 5% gels (100 V, 90 min) and transferred to nitrocellulose membranes (90 V, 90 min). All Photos (1) Documents. A320. Another report showed that BD2-selective BET family inhibitors exhibited good efficacies in treating prostate cancer 22. All Photos (1) SML3234. Figure 4. Their affinities for the individual bromodomains of the BET family were initially determined by TR-FRET (Fig. 5 upper limit of normal (ULN) Total bilirubin < 1. Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months). Data and materials availability: I-BET151, GSK778, GSK046, and GSK620 are available from R. All Photos (1) Documents. Developing BDII selective compounds was far more challenging, and only a handful of BDII selective inhibitors have been developed to date (Figure 1). ≥98% (HPLC)We used the BD1-selective small molecule inhibitor GSK778, which largely phenocopies pan-BET inhibitors, as well as the BD2-selective inhibitor GSK046, which has more limited effects on steady. 1A). COO/ COA. 00. WGK 3. GSK778 Hydrochloride ≥98% (HPLC); Synonyms: 4-{2-(Methoxymethyl)-1-[(R)-1-phenylethyl]-8-[(S)-pyrrolidin-3-ylmethoxy]-1H-imidazo[4,5-c]quinolin-7-yl}-3,5. SML3234. 2451862-42-1. Email. Adequate renal, hepatic, pulmonary and cardiac function defined as: Creatinine clearance (as estimated by Cockcroft Gault) > 60 mL/min. 9. 27,42 The second-generation BRD4 inhibitors are mainly synthesized by proteolysis targeting chimera (PROTAC) technology. Hazard identification. MR EN. GSK778 Hydrochloride. GSK778 phenocopies the effects of pan- BET inhibitors in cancer models. 11 - Combustible Solids. BD1 selective inhibitors, such as GSK778, MS-436, Olinone, and BI-2536, as well as the BD2 selective inhibitors RVX-208, RVX-297, GSK046, and ABBV-744 have been produced. Copy Link. , 2010), BD1-specific GSK778 and BD2-specific ABBV-774 and GSK046 (Faivre et al. toronto@thesgc. Here, we report two unexpected findings: (1) SynGRs bearing pan-BET or BD2-selective ligands license transcription at the FXN locus, whereas those bearing BD1-selective ligands do not, and (2) rather than being neutral or inhibitory, an untethered BD1-selective ligand (GSK778) substantively enhances the activity of all active SynGRs. iBET-BD1 dihydrochloride . Available to order from Sigma-Aldrich. GSK778, a potent pan-D1 inhibitor, was reported by Gilan et al. Description: GSK778, also known as iBET-BD1, is a potent and selective inhibitor of bromodomain (BRD) BD1, with IC50s of 75 nM (BRD2 BD1). Solicite agora um orçamentoGSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. ≥98% (HPLC)Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). Applications Products Services Documents Support. COO/ COA. 1 in RR-multiple myeloma CC-94280 HIGHLIGHTS FROM DRUG DISCOVERY ARTICLES PUBLISHED ONLINE | MAR. Thus, BRD4 is a target for the treatment of glioma. Federal government websites often end in . GSK778 phenocopied the effects of pan-BET inhibitors in cancer models. The two novel ‘iBET’ molecules display the. The calculations of the energy contributions of individual residues demonstrate that residues corresponding to (BD1, BD2) generate significant energy difference in binding of SG3-179, GSK778, and. In contrast to pan-BET proteins inhibitors, these selective BET proteins inhibitors of BD1 or BD2 are characterizedCas No. 1. GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. 00. Binding free energy predictions suggest that entropy changes, electrostatic interactions, and van der Waals interactions are key factors in the selective binding of BD1 and BD2 by SG3-179, GSK778. SML3234. GSK778 Hydrochloride ≥98% (HPLC); Synonyms: 4-{2-(Methoxymethyl)-1-[(R)-1-phenylethyl]-8-[(S)-pyrrolidin-3-ylmethoxy]-1H-imidazo[4,5-c]quinolin-7-yl}-3,5. All Photos (1) Documents. , 2016). All Photos (1) SML3234. Catalog No. Copy Link. GSK778 is a potent and selective inhibitor of BD1 bromodomain such as BRD2 BD1 (IC50s = 75 nM), BRD3 BD1 (IC50s = 41 nM), BRD4 BD1 (IC50s = 41 nM), and BRDT BD1 (IC50s = 143 nM). * Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients. GSK789 was derived from a series of naphthyridone ATAD2 inhibitors. Email. While GSK789 was less selective (TAF1-BD2 K d = 50 nM and TAF1L-BD2 K d = 398 nM), it. Chemical probes are cell-active, selective, highly validated research tools that can be used to decipher the biology of their target. GSK778 Hydrochloride ≥98% (HPLC); Synonyms: 4-{2-(Methoxymethyl)-1-[(R)-1-phenylethyl]-8-[(S)-pyrrolidin-3-ylmethoxy]-1H-imidazo[4,5-c]quinolin-7-yl}-3,5. GSK778 (iBET-BD1) is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively. , 2020). The two tandem. All Photos (1) Documents. ChemicalBook 为您提供FREEBASE(2451862-42-1)的化学性质,熔点,沸点,密度,分子式,分子量,物理性质,毒性,结构式,海关编码等信息,同时您还可以浏览FREEBASE(2451862-42-1)产品的价格,供应商,贸易商,生产企业和生产厂家,最后FREEBASE(2451862-42-1)的中文,英文,用途,CAS,上下游产品信息可能也是您. Applications Products Services Documents Support. GSK778 phenocopies the effects of pan-BET inhibitors in cancer models. Available to order from Sigma-Aldrich. Copy Link. Hazard identification. All Photos (1) SML3234. GSK778 hydrochloride hydrochloride phenocopies the effects of pan-BET inhibitors in cancer models[1]. GSK778 (iBET-BD1) is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC 50 s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively. GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. amni) under a material transfer agreement with GSK. WGK 3. Safety Information. Preis und Verfügbarkeit anzeigen. The BD2 selective inhibitor RVX-208 could significantly decrease atherosclerosis in hyperlipidemic apolipoprotein E-deficient mice 14 , and increase high-density lipoprotein cholesterol as well as apolipoprotein A-1 in monkeys 15 . Available to order from Sigma-Aldrich. Dagrocorat. RVX-297 is a 4-quinazolinone derivative related to RVX-208 with an alkylpyrrolidine side chain off the di-methyl substituted phenyl ring (Fig. GSK778 Catalog No. GSK778 (iBET-BD1) potently inhibits numerous cancer cells proliferation, inducing cell cycle arrest and apoptosis. IC₅₀ & Target BRD2 BD1 75 nM (IC50) BRD3 BD1 41 nM. 13 Similar interactions were found by our recently reported triazole-based inhibitors, including DW34, which exhibit pan-D1 selectivity, with. 6147. AA Blocks. SML3234. ≥98% (HPLC)Despite their profound preclinical efficacy, the clinical utility of pan-inhibitors is limited due to observed cytotoxicicities. Chemical Structure. In recent years, members of the bromodomain and. S9683 Synonyms: iBET-BD1. Gamma (γ) Secretase (GS) Inhibitors. GSK778 Hydrochloride. Instead, a unique effect of BD2-selective antagonism was revealed with GSK046, affecting the induction of gene expression more so than the expression of steady-state genes, in contrast to GSK778 [28]. WGK 3. Selectivity profile of I-BET151, iBET-BD1 (GSK778) and iBET-BD2 (GSK046). Email. Código de clase de almacenamiento. 2h 41m. FRAP, BAZ2A: 1000 1-25719566: 10 GSK2801. BET proteins are linked to cancer progression. KR EN. 511. 125 nM (MV-4−11 cells) ≤. iBET-BD1 dihydrochloride . SML3234. COO/ COA. COO/ COA. In spite of the structural similarity to RVX-208, RVX-297 has demonstrated a different pharmacodynamical profile, as well as distinct cellular and biological activity which was elucidated in the. ≥98% (HPLC)Shop Medchemexpress LLC HY-136570 5mg , GSK778 CAS:2451862-42-1 Purity:>98% at Fishersci. 3; Cell proliferation assay with the AML cell line MV-4−11 that has a MLL-AF4 rearrangement (3 days): growth inhibition with pIC50 = 7. Given the high sequence similarity amongst BET bromodomains, small molecule inhibitors for a single BET bromodomain are lacking; however, potent pan-D2 inhibitors (e. GSK778. WGK. ≥98% (HPLC)GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. Among this class, RVX-208 mainly blocks BD2 function [99], whereas GSK778 is a BD1 selective inhibitor [99]. Potency in Cells and Cellular Target Engagement: GSK778 engages the target in HEK293 cells: pIC50 = 7. All Photos (1) Documents. We do not sell to patients. 9. Their affinities for the individual bromodomains of the BET family were initially determined by TR-FRET (Fig. GSK778 Hydrochloride ≥98% (HPLC); Synonyms: 4-{2-(Methoxymethyl)-1-[(R)-1-phenylethyl]-8-[(S)-pyrrolidin-3-ylmethoxy]-1H-imidazo[4,5-c]quinolin-7-yl}-3,5. The two tandem bromodomains of the BET proteins enable chromatin binding to facilitate transcription. GSK778 Hydrochloride. GSK778 Hydrochloride. MOscan analysis of GSK778 indicated the binding of this compound only to BET bromodomains with strong binding to BET BD1 domains while weakly binding to BET BD2 domains. 65 ABBV-744 shows potent anti-proliferative effects against. GSK778 Hydrochloride. GSK778 has a more pronounced effect on the growth and viability of MDA-453, MOLM-13, K562, MV4-11, THP-1, and MDA-MB-231 cells, GSK778 reduces the clonogenic capacity of primary human AML cells. GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. 14 Whereas a pan-BET inhibitor impeded differentiation of oligodendrocytes, olinone induced this process. (C) X-ray crystal structure of I-BET151 in. GSK778 Hydrochloride. CAS# 2451862-42-1. All Photos (1) SML3234. Copy Link. (B) Compound binding to the individual bromodomains of BD1 (orange) and BD2 (cyan) of BET tandem bromodomains in TR-FRET assays. 1B and fig. , 2016). If not otherwise indicated, cells were pretreated with I-BET151, iBET-BD1, iBET-BD2 or vehicle (DMSO) for 48 hours, irradiated with 0 or 6 Gy, and incubated for additional time intervals with concurrent drug. Shelf Life: >3 years if stored properly. P. MS EN. Recently, inhibitors were developed that selectively target the first (BD1) and second (BD2) bromodomain of the BET proteins (iBET-BD1 [GSK778] and iBET-BD2 [GSK046]). TC EN. Forodesine hydrochloride ≥98% (HPLC); Synonyms: 7-[(2S,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one, hydrochloride salt,BCX-1777 HCl,ImmH HCl,Immucillin-H HCl; find Sigma-Aldrich-SML3378 MSDS, related peer-reviewed papers, technical documents, similar products & more at Sigma. GSK778 Hydrochloride. GSK778 (iBET-BD1) is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC 50 s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively. 6SWN: N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH iBET-BD1 (GSK778) PDB ID: 6SWN Download: MMDB ID: 192697: PDB Deposition Date: 2019/9/22: Updated in MMDB: 2021/02: Experimental Method: x-ray diffraction. The . 1B, fig. HY-136570 25mg GSK778 CAS: 2451862-42-1 GSK778 (iBET-BD1) is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively. GSK778 Hydrochloride. Comparison of the binding modes of CDD-956 with BD1, CDD-1302 with BRDT-BD2 , and iBET-BD1 (GSK778) with BRD4-BD1 (Fig. GSK778 phenocopied the effects of pan-BET inhibitors in cancer models. iBET-BD1 phenocopies the effects of pan-BET inhibitors in cancer models, whereas iBET-BD2 is predominantly effective in. We would like to show you a description here but the site won’t allow us. Selectivity profile of I-BET151, iBET-BD1 (GSK778) and iBET-BD2 (GSK046). GSK778 Hydrochloride ≥98% (HPLC); Synonyms: 4-{2-(Methoxymethyl)-1-[(R)-1-phenylethyl]-8-[(S)-pyrrolidin-3-ylmethoxy]-1H-imidazo[4,5-c]quinolin-7-yl}-3,5. 6SWO: C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH iBET-BD1 (GSK778) PDB ID: 6SWO Download: MMDB ID: 192698: PDB Deposition Date: 2019/9/22: Updated in MMDB: 2021/02: Experimental Method: x-ray diffraction. COO/ COA. g ABBV-744, Fig. GSK778 (68), yielded by introducing an additional pyrrolidine to compound 19 (Fig. gov means it’s official. GSK778 (iBET-BD1) is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. SML3234. GSK778 GSK778 : BD1 selective inhibitor of BRD2, BRD3, BRD4, BRDT Structure. SML3234. The calculations of the energy contributions of individual residues demonstrate that residues corresponding to (BD1, BD2) generate significant energy difference in binding of SG3-179, GSK778, and. GSK778 Hydrochloride ≥98% (HPLC); Synonyms: 4-{2-(Methoxymethyl)-1-[(R)-1-phenylethyl]-8-[(S)-pyrrolidin-3-ylmethoxy]-1H-imidazo[4,5-c]quinolin-7-yl}-3,5. COO/ COA. Storage Class Code. 5. 10 µM; GSK791. GSK778 Hydrochloride ≥98% (HPLC); Synonyms: 4-{2-(Methoxymethyl)-1-[(R)-1-phenylethyl]-8-[(S)-pyrrolidin-3-ylmethoxy]-1H-imidazo[4,5-c]quinolin-7-yl}-3,5. , 2020; Gilan et al. • GSK778 exhibits >130-fold BD1 selectivity over BD2 due to BD1 Asp144/His433 displacement (Kharenko et al. BRD3 (BD1) pIC. GSK778 Hydrochloride ≥98% (HPLC); Synonyms: 4-{2-(Methoxymethyl)-1-[(R)-1-phenylethyl]-8-[(S)-pyrrolidin-3-ylmethoxy]-1H-imidazo[4,5-c]quinolin-7-yl}-3,5. Applications Products Services Documents Support. Well-characterized small molecules are essential tools for studying the biology and therapeutic relevance of a target protein. Copy Link. Available to order from Sigma-Aldrich. GSK778 (iBET-BD1) is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC 50 s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively. 61: Synonym: GSK778;4-[2-(methoxymethyl)-1-[(1~{R})-1-phenylethyl]-8-[[(3~{S})-pyrrolidin-3-yl. ChemScene Provide GSK778(CAS 2451862-42-1)In-stock or Backordered impurities,Bulk custom synthesis,Formular C30H33N5O3,MW 511. 7 B) indicated that GSK778 maintains all of the critical interactions of I-BET151 with BRD4-BD1, including the hydrogen bonding interaction of the 3,5-dimethylisoxazole moiety with the conserved Asn140, the hydrophobic interaction of the aryl ring of the α-methylbenzyl group with the. GSK778 (iBET-BD1) potently inhibits numerous cancer cells proliferation, inducing cell cycle arrest and apoptosis. Available to order from Sigma-Aldrich. Drugs that inhibit both bromodomains equally have shown efficacy in certain malignant and inflammatory conditions. GSK778 (iBET-BD1) potently inhibits numerous cancer cells proliferation, inducing cell cycle arrest and apoptosis. All Photos (1) Documents. GSK778. By Louis Gilman. Related Post. Shelf Life: >2 years if stored properly. ≥98% (HPLC)GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. GSK778: CAS Registry Number: 2451862-42-1: Molecular Weight: 511. Meanwhile, GSK778 has IC 50 s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively. GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT. Open in a separate window. , 2013). Developing selective chemical probes for the BET subfamily. Safety Information. COO/ COA. Their affinities for the individual bromodomains of the BET family were initially determined by TR-FRET (Fig. Copy Link. GSK778 Hydrochloride is a potent and highly selective inhibitor of bromodomain BD1 of BRD2, BDR3, BRD4, BRDT.